Feeding Jejunostomy after esophagectomy cannot be routinely recommended. Analysis of nutritional benefits and catheter-related complications
Autores de IIS La Fe
Grupos
Abstract
Background: Patients undergoing esophagectomy for cancer usually deal with malnourishment which increases postoperative morbimortality. The objective of this paper is to analyze the nutritional benefits of feeding jejunostomy (FJ) for early postoperative enteral nutrition (EN) and directly-related complications. Material and methods: Retrospective study of 100 patients undergoing esophagectomy for cancer between 2008 and 2016. Results: FJ was placed in 47 patients. 82.98% reached EN requirements in FJ group, with a median EN restart of 1.9 days and median days to objective requirements of 5 days. 51.06% developed directly-related FJ complication, 91.66% of them mild ones (gastrointestinal or catheter-related). 2 patients (4.25%) required re-intervention. No significant differences were shown in total protein and albumin seric levels during first postoperative week and in anastomotic leak rate between both groups (p > 0.05). Conclusions: Feeding jejunostomies are associated with a great number of complications although most are not life-threatening. Since its nutritional benefit is not proven FJ cannot routinely recommended after esophagectomy. However, the optimal pathway for EN reintroduction, including direct oral intake, is still a matter of debate. (C) 2018 Elsevier Inc. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 0002-9610, 1879-1883
- Tipo:
- Article
- Páginas:
- 114-120
- PubMed:
- 30309617
- Factor de Impacto:
- 1,030 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
AMERICAN JOURNAL OF SURGERY EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC
Citas Recibidas en Web of Science: 20
Documentos
- No hay documentos
Filiaciones
Proyectos y Estudios Clínicos
MODELOS DE HÍGADO AISLADO PERFUNDIDO PARA EL RESCATE DE ÓRGANOS Y TRASLACIÓN DE LA TERAPIA GÉNICA EN EL TRASPLANTE: ESCENARIOS HUMANO "EX VIVO" Y PORCINO "IN VIVO"
Investigador Principal: RAFAEL LÓPEZ ANDÚJAR
2017_0270_CRC_LOPEZ . FUNDACION MUTUA MADRILEÑA . 2017
Ileostomía vistual combinada con endoscopia postoperatoria ebn cáncer de recto con escisión total mesorrectal. ¿podemos evitar estomas innecesarios? estudio prospectivo observacional multicénctrico.
Investigador Principal: BLAS FLOR LORENTE
PI17/00863 . INSTITUTO DE SALUD CARLOS III . 2018
Terápia génica no-viral con 1L 10 para el tratamiento de la enfermedad inflamatoria intestinal. Estudio preliminar con piezas de cólon humano ex vivo.
Investigador Principal: MATTEO FRASSON
PI18/01658 . INSTITUTO DE SALUD CARLOS III . 2019
ESTUDIO PROSPECTIVO, ALEATORIZADO, DOBLE-CIEGO, INTERNACIONAL Y MULTICÉNTRICO SOBRE LA SEGURIDAD Y LA EFICACIA DE LA SOLUCIÓN 6% HIDROXIETIL ALMIDÓN (HYDROXYETHYL STARCH) (HES) COMPARADA CON UNA SOLUCIÓN ELECTROLÍTICA EN PACIENTES SOMETIDOS A CIRUGÍA ABDOMINAL: ESTUDIO PHOENICS.
Investigador Principal: ÓSCAR DÍAZ CAMBRONERO
HC-G-H-1504 (PHOENICS) . 2018
ESTUDIO ALEATORIZADO MULTICÉNTRICO EN FASE III DE RADIOTERAPIA DE CORTA DURACIÓN SEGUIDA DE QUIMIOTERAPIA PREOPERATORIA DE LARGA DURACIÓN Y CIRUGÍA EN EL CÁNCER RECTAL PRIMARIO DE ALTO RIESGO EN COMPARACIÓN CON QUIMIORRADIOTERAPIA CONVENCIONAL Y CIRUGÍA Y OPTIMA QUIMIOTERAPIA ADYUVANTE.
Investigador Principal: JORGE APARICIO URTASUN
RAPIDO
Cita
ALVAREZ E,NAVARRO FM,ROSELLON RJ,PLA NB,URBANEJA FJV,GALLARDO CM,RUBIO ML,XIMENEZ E. Feeding Jejunostomy after esophagectomy cannot be routinely recommended. Analysis of nutritional benefits and catheter-related complications. Am J Surg. 2019. 217. (1):p. 114-120. IF:2,125. (2).